CompletedPhase 2NCT02727387
Protocol for the Treatment of Metastatic Ewing Sarcoma
Studying Extraskeletal Ewing sarcoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Italian Sarcoma Group
- Principal Investigator
- Roberto Luksch, MDFondazione IRCCS Istituto Nazionale dei Tumori, Milano
- Intervention
- TEMIRI(drug)
- Enrollment
- 155 enrolled
- Eligibility
- 40 years · All sexes
- Timeline
- 2009 – 2022
Study locations (13)
- Centro di Riferimento Oncologico - Unit of Medical Oncology, Aviano, Pordenone, Italy
- I.R.C.C. - Unit of Medical Oncology, Candiolo, Torino, Italy
- Azienda ospedaliero universitaria consorziale policlinico - bari, Bari, Italy
- Istituto Ortopedico Rizzoli - Unit of Chemotherapy of Muscoloskeletal Tumors, Bologna, Italy
- Servizio di Oncoematologi Pediatrica Ospedale microcitemico ASL 8, Cagliari, Italy
- A.O. Universitaria Meyer, Florence, Italy
- Istituto Giannina Gaslini, Genova, Italy
- Fondazione IRCCS INT Milano, Milan, Italy
- Azienda Ospedaliera di Padova, Padua, Italy
- Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy
- Ospedale Pediatrico Bambin Gesu', Roma, Italy
- Ospedale Infantile Regina Margherita - Unit of Paediatric Oncoematology, Torino, Italy
- IRCCS materno infantile Burlo Garofolo, Trieste, Italy
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02727387 on ClinicalTrials.gov